Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
CARL
CARL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CARL News
Carlsmed Reports Q4 Earnings Beat with Strong Revenue Growth Outlook
Feb 26 2026
seekingalpha
Carlsmed, Inc. Reports Strong Q4 2025 Earnings and Growth Outlook
Feb 26 2026
seekingalpha
Carlsmed Reports 86% Revenue Growth in 2025 Financial Results
Feb 25 2026
Yahoo Finance
Carlsmed Achieves Milestone in Personalized Cervical Plating Procedure
Feb 19 2026
Benzinga
Carlsmed to Report Q4 and Full Year 2025 Results on February 25
Feb 11 2026
Yahoo Finance
Heineken Plans 7% Workforce Layoffs to Boost Efficiency
Feb 11 2026
CNBC
Carlsmed Completes First Lumbar Spine Surgery with Aprevo System
Feb 10 2026
Newsfilter
Danish Brewer's Earnings Decline Amid Increased Soft Drink Reliance
Feb 04 2026
Yahoo Finance
Novo Nordisk Warns of Sales Decline Amid Price Pressures
Feb 04 2026
CNBC
Trump Reaches Greenland Framework Agreement, European Stocks Rise
Jan 22 2026
CNBC
Carlsmed CEO Mike Cordonnier to Present at J.P. Morgan 2026 Healthcare Conference
Dec 16 2025
Globenewswire
CARL Introduces Aprevo Cervical Platform for Customized Spine Surgery
Dec 09 2025
NASDAQ.COM
Carlsmed Launches aprevo® Technology Platform for Cervical Fusion Surgeries
Dec 03 2025
Globenewswire
Carlsmed Launches aprevo® Technology Platform for Cervical Fusion Surgeries
Dec 03 2025
Newsfilter
Truist Securities Maintains Buy Rating on Carlsmed, Increases Price Target to $20
Nov 07 2025
Benzinga
BTIG Reaffirms Buy Rating on Carlsmed, Increases Price Target to $24
Nov 07 2025
Benzinga
Show More News
